Advocacy intelligence hub — real-time data for patient organizations
Memorial Sloan Kettering Cancer Center — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Francesco Doglietto, Prof
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Andrew Lin, MD
Memorial Sloan Kettering Cancer Center
Ying Ru, MD, PhD
Corcept Therapeutics
Kris Ann P Schultz, MD
Children's Minnesota
Sandip P Patel
SWOG Cancer Research Network
📍 Birmingham, Alabama
Coleman Gross, MD, MD
Corcept Therapeutics
📍 MCMINNVILLE, OR